Who Paid My Doc
Vishakha Sabharwal
Pediatric Infectious Diseases Boston, MA
NPI 1538148044 CMS profile 634664
850 Harrison Ave, Yacc5, Boston, MA 02118
General payments
$0
Research payments
$0
Ownership & investment interest
$0
The CMS Open Payments record contains no reported payments to Vishakha Sabharwal of Boston, MA.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
Other Pediatric Infectious Diseases in Massachusetts
Stephen Pelton
Pediatric Infectious Diseases · Boston, MA
Rotem Lapidot
Pediatric Infectious Diseases · Boston, MA
Richard Malley
Pediatric Infectious Diseases · Boston, MA
Ofer Levy
Pediatric Infectious Diseases · Boston, MA
Cheryl Pikora
Pediatric Infectious Diseases · Worcester, MA
Elizabeth Barnett
Pediatric Infectious Diseases · Boston, MA
Related records
Pediatric Infectious Diseases in Massachusetts
Practitioners in the same specialty and state, ranked by reported value.
All Pediatric Infectious Diseases
Everyone recorded under this specialty, nationwide.
Doctors in Massachusetts
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.